rs113993980
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_002863.5(PYGL):c.1471C>T(p.Arg491Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/24 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R491H) has been classified as Uncertain significance.
Frequency
Consequence
NM_002863.5 missense
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease VIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PYGL | ENST00000216392.8 | c.1471C>T | p.Arg491Cys | missense_variant | Exon 12 of 20 | 1 | NM_002863.5 | ENSP00000216392.7 | ||
| PYGL | ENST00000532462.5 | c.1471C>T | p.Arg491Cys | missense_variant | Exon 12 of 20 | 1 | ENSP00000431657.1 | |||
| PYGL | ENST00000544180.6 | c.1369C>T | p.Arg457Cys | missense_variant | Exon 11 of 19 | 2 | ENSP00000443787.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152128Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251460 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461766Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727202 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74312 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Glycogen storage disease, type VI Pathogenic:1Other:1
Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 491 of the PYGL protein (p.Arg491Cys). This variant is present in population databases (rs113993980, gnomAD 0.007%). This missense change has been observed in individuals with clinical features of glycogen storage disease (PMID: 17705025; Invitae). ClinVar contains an entry for this variant (Variation ID: 21329). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PYGL protein function. This variant disrupts the p.Arg491 amino acid residue in PYGL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 33763395). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
not specified Uncertain:1
Variant summary: PYGL c.1471C>T (p.Arg491Cys) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant allele was found at a frequency of 2.4e-05 in 251460 control chromosomes. c.1471C>T has been reported in the literature in individuals affected with Glycogen storage disease, type VI (example: Beauchamp_2007, internal data). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 17705025). ClinVar contains an entry for this variant (Variation ID: 21329). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at